Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04210024 · ClinicalTrials.gov registry record · NA

Social Network Analysis to Identify Community Health Workers

A NA study, sponsored by Brittany L Smalls.

Completed
Registry status
NA
Development phase
91
Enrollment target

NCT04210024: Completed NA study, sponsored by Brittany L Smalls.

NCT04210024 is a NA study that has completed, run by Brittany L Smalls. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04210024, a NA study, has completed, sponsored by Brittany L Smalls.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target

Study Summary

The objective of this study is to recruit influential community members using Snowball Sampling Methods. Community members identified through social network analysis as influential and well-connected will be trained as community health workers (CHW) using the Diabetes Empowerment Education Program (DEEP). These CHW will be used in a future trial to educate other members of the community.

Primary Outcome

The change in participants' knowledge of Type 2 Diabetes Mellitus (T2DM) will be assessed using the Diabetes Knowledge Questionnaire (DKQ) pre- and post-training with the DEEP program. The DKQ is a 24-item survey assessing diabetes knowledge. Scores range from 0-24; higher scores indicate increased knowledge of diabetes.

Interventions

  • OTHER Diabetes Empowerment Education Program

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2019-05-03
Est. Completion 2023-08-10
Phase NA
Brittany L Smalls

3 total trials

What the finished NCT04210024 record still lists

NCT04210024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Diabetes Empowerment Education Program is the first listed.

NCT04210024 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04210024 about?

NCT04210024 is a clinical study titled "Social Network Analysis to Identify Community Health Workers". The objective of this study is to recruit influential community members using Snowball Sampling Methods. Community members identified through social network analysis as influential and well-connected will be trained as community health workers (CHW) using the Diabetes Empowerment Education Program (...

What is the current status of trial NCT04210024?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2019-05-03. Estimated completion is 2023-08-10.

What interventions are being tested in trial NCT04210024?

The interventions under investigation include: Diabetes Empowerment Education Program (OTHER).

Who is sponsoring clinical trial NCT04210024?

This trial is sponsored by Brittany L Smalls, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04210024's enrollment target sits among peer trials

91 939th of 2000 higher than 1,060 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02671448 · 91 participants · NA

    Pilot Trial of Homebound Stem Cell Transplantation

  • NCT04835857 · 91 participants

    Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices

  • NCT05184842 · 91 participants · Phase 2

    Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML

  • NCT05685173 · 91 participants · Phase 1

    A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04210024, the US trial registry maintained by the National Library of Medicine. NCT04210024 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.